Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

25.56
-0.8100-3.07%
Post-market: 25.560.00000.00%18:23 EDT
Volume:742.30K
Turnover:19.32M
Market Cap:1.51B
PE:-19.91
High:28.13
Open:26.25
Low:25.44
Close:26.37
Loading ...

Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com

Dow Jones
·
09 Jan

Janux Therapeutics CEO sells $1.4M in common stock

TIPRANKS
·
30 Dec 2024

LifeSci Capital Initiates a Buy Rating on Janux Therapeutics Inc (JANX)

TIPRANKS
·
27 Dec 2024

Stock Track | Janux Therapeutics Soars 5.08% as BTIG Maintains Buy Rating

Stock Track
·
10 Dec 2024

BTIG Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

TIPRANKS
·
10 Dec 2024

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Kura Oncology (KURA)

TIPRANKS
·
08 Dec 2024

BRIEF-Janux Therapeutics Closes Public Offering For Proceeds Of $402.5 Mln

Reuters
·
07 Dec 2024

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

THOMSON REUTERS
·
07 Dec 2024

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

Business Wire
·
07 Dec 2024

BUZZ-Janux Therapeutics notches fresh record after $350 mln equity raise

Reuters
·
05 Dec 2024

Bank of America Securities Gives a Buy Rating to Janux Therapeutics Inc (JANX)

TIPRANKS
·
05 Dec 2024

Janux Therapeutics Inc (JANX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
05 Dec 2024

TD Cowen Remains a Buy on Janux Therapeutics Inc (JANX)

TIPRANKS
·
05 Dec 2024

Janux Therapeutics Prices $350 Million Offering of Shares, Warrants

MT Newswires Live
·
05 Dec 2024

Janux Therapeutics 5.32M share Secondary priced at $63.00

TIPRANKS
·
05 Dec 2024

BRIEF-Janux Therapeutics Announces Pricing Of $350.0 Million Underwritten Public Offering Of Common Stock

Reuters
·
05 Dec 2024

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
05 Dec 2024

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Business Wire
·
05 Dec 2024

Why Janux Therapeutics Crushed the Market Today

Motley Fool
·
05 Dec 2024

JANX Stock Hits Record High on Prostate Cancer Study Data

Zacks
·
04 Dec 2024